1Park H,Adamson L,Ha T. Polyinosinic-polycytidylic acid is the most effective TLR adjuvant for SIV Gag proteininduced T cell responses in nonhuman primates[J].{H}Journal of Immunology,2013,(8):4103-4115.
2Huang YK,Zheng Z,Cheng CX. The antitumor effect of the toll-like receptor 3 ligand polyinosinic-cytidylic acid as an adjuvant[J].{H}Cancer Immunology lmmunotherapy,2013,(2):237-244.
3Cao Y,Lu Z,Li Y. Poly (I:C) combined with multi-epitope protein vaccine completely protects against virulent foot-and-mouth disease virus challenge in pigs[J].{H}Antiviral Research,2013,(2):145-153.
4Li YG,Siripanyaphinyo U,Tumkosit U. Poly (I:C),an agonist of toll-like receptor-3,inhibits replication of the Chikungunya virus in BEAS-2B cells[J].{H}VIROLOGY JOURNAL,2012,(1):114-121.
5Cao Y,Lu Z,Li P. Improved neutralising antibody response against foot-and-mouth-disease virus in mice inoculated with a multi-epitope peptide vaccine using polyinosinic and poly-cytidylic acid as an adjuvant[J].{H}Journal of Virological Methods,2012,(1):124-128.
6Inao T,Harashima N,Monma H. Antitumor effects of cytoplasmic delivery of an innate adjuvant receptor ligand,poly (I:C),on human breast cancer[J].{H}Breast Cancer Research and Treatment,2012,(1):89-100.
7Charerntantanakul W. Adjuvants for porcine reproductive and respiratory syndrome virus vaccines[J].{H}Veterinary Immunology and Immunopathology,2009,(1-2):1-13.
